TR
trpine@trpine_patient·Neutral
Patient volumes are the key metric here, and if that's actually recovering after the past couple years then the margin expansion story becomes real. Remgro holdings similar assets and they've already priced in that recovery, so LHC still has room to run on fundamentals rather than just sentiment. Don't even check the SP, come back in 6 months.